Allogene Therapeutics Q4 Earnings Call Highlights.
Share this article
Earnings
Score 55
Neutral
Allogene Therapeutics Q4 Earnings Call Highlights
Mar 12, 2026 23:46 UTC
ALLO, XLV, IHF
Short term
Related Articles
Score 75
Bearish
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Mar 15, 21:56
Score 72
Bullish
Thermo Fisher Scientific Inc. (TMO) Positioned for Robust Growth on AI Integration and Acquisition Boost
Mar 15, 21:55
Score 45
Bullish
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress?
Mar 15, 21:54
Score 65
Bullish
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Mar 15, 21:52
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.